Solid organ transplantation (SOT) is a life-saving procedure and an established treatment for
patients with end-stage organ failure. However, transplantation is also accompanied by …

Post-transplant diabetes mellitus (PTDM) is a frequent consequence of solid organ
transplantation. PTDM has been associated with greater mortality and increased infections …

Transplantation of pancreatic islets is a promising strategy to alleviate the unstable blood‐
glucose control that some patients with diabetes type 1 exhibit and has seen many …

Post-liver transplantation diabetes mellitus (PLTDM) develops in up to 30% of liver
transplant recipients and is associated with increased risk of mortality and multiple morbid …

Solid organ transplantation (SOT) is an established therapeutic option for chronic disease
resulting from end-stage organ dysfunction. Long-term use of immunosuppression is …

Interventions that extend lifespan in mice can show substantial sexual dimorphism. Here, we
show that male‐specific lifespan extension with two pharmacological treatments, acarbose …

Context: Immunosuppressive agents are associated with profound metabolic side effects
including new-onset diabetes and dyslipidemia after organ transplantation. Objective: To …

Context The management of solid-organ transplantation is rapidly evolving, and
posttransplant diabetes mellitus (PTDM), which is increasingly common, is a barrier to …

Objective This systematic review describes the efficacy, safety, and drug interactions of
dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1 …

Post‐transplant diabetes mellitus (PTDM) is a common complication of solid organ
transplantation and a major cause of increased morbidity and mortality. Additionally, solid …